Breakthroughs in anti-aging biotech could create a multi-trillion-dollar industry, as living longer becomes a top priority for an increasing number of Americans.

Charles Payne is joined by longevity biotech co-founder Marc Bernegger, whose company Maximon focuses on making healthier aging a reality. Marc shares a few technological advancements (e.g., GLP-1s), which factors are driving extended lifespans, and the ripe opportunity to invest in biotech before it becomes a "mass phenomenon."

Catch his town hall special, "Unbreakable Investor: Live Forever and Prosper" on FOX Business this Thursday, July 24, at 2 PM Eastern.

Learn more about your ad choices. Visit podcastchoices.com/adchoices